Evidence map›Paper›PMID 27158328›Full record

ArticleAmerican journal of translational research2016

Mineralocorticoid receptor is involved in the aldosterone pathway in human red blood cells.

Luciana Bordin, Carlo Saccardi, Gabriella Donà, Chiara Sabbadin, Alessandra Andrisani, Guido Ambrosini, Mario Plebani, Anna Maria Brunati, Eugenio Ragazzi, Salvatore Gizzo and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Role of adrenocorticotropic hormone in essential hypertension and primary aldosteronism.Journal of clinical hypertension (Greenwich, Conn.) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Luciana BordinDepartment of Molecular Medicine-Biological Chemistry, University of Padua Padua, Italy.
Carlo SaccardiDepartment of Woman and Child Health, University of Padua Padua, Italy.
Gabriella DonàDepartment of Molecular Medicine-Biological Chemistry, University of Padua Padua, Italy.
Chiara SabbadinDepartment of Medicine, University of Padua Padua, Italy.
Alessandra AndrisaniDepartment of Woman and Child Health, University of Padua Padua, Italy.
Guido AmbrosiniDepartment of Woman and Child Health, University of Padua Padua, Italy.
Mario PlebaniDepartment of Laboratory Medicine, University of Padua Padua, Italy.
Anna Maria BrunatiDepartment of Molecular Medicine-Biological Chemistry, University of Padua Padua, Italy.
Eugenio RagazziDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua Padua, Italy.
Salvatore GizzoDepartment of Woman and Child Health, University of Padua Padua, Italy.
Decio ArmaniniDepartment of Medicine, University of Padua Padua, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have recently demonstrated that excessive aldosterone (Aldo) secretion in primary aldosteronism (PA) is associated with red blood cells (RBC) senescence. These alterations were prevented/inhibited by cortisol (Cort) or canrenone (Can) raising the hypothesis that Aldo effects in RBC may be mediated by mineralocorticoid receptor (MR), though to date MR has never been demonstrated in human RBC. The aim of this multicenter comparative study was to investigate whether Aldo effects were mediated by MR in these a-nucleated cells. We included 12 healthy controls (HC) and 22 patients with PA. MR presence and activation were evaluated in RBC cytosol by glycerol gradient sedimentation, Western blotting, immuno-precipitation and radioimmunoassay. We demonstrated that RBC contained cytosolic MR, aggregated with HSP90 and other proteins to form multiprotein complex. Aldo induced MR to release from the complex and to form MR dimers which were quickly proteolyzed. Cort induced MR release but not dimers formation while Can was not able to induce MR release. In addition, RBC cytosol from PA patients contained significantly higher amounts of both MR fragments (p<0.0001) and Aldo (p<0.0001) concentrations. In conclusion, in RBC a genomic-like Aldo pathway is proposed involving MR activation, dimerization and proteolysis, but lacking nuclear transcription. In addition, dimers proteolysis may ensure a sort of Aldo scavenging from circulation by entrapping Aldo in MR fragments.

Indexed as

cellular senescencecortisolHSP-90human red blood cellsMineralocorticoid receptorprimary aldosteronism

Identifiers

PMID27158328
PMCPMC4846885
OpenAlexW2404048657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.